Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Traditional Chinese Medicine Co., Ltd. is a prominent pharmaceutical enterprise based in Nanjing, China, specializing in the research, development, production, and distribution of Traditional Chinese Medicine (TCM). Founded in 1956, the company operates as a key subsidiary of China Resources Pharmaceutical Group, leveraging a legacy of nearly seven decades in the herbal medicine sector. Its business model covers the entire TCM industrial chain, from the standardized cultivation of medicinal plants to the manufacturing of high-quality decoction pieces and proprietary patent medicines. The company's flagship products, such as Suhuai Granules, are widely used in the treatment of chronic conditions like ulcerative colitis. With state-of-the-art GMP-certified facilities, Jiangsu Traditional Chinese Medicine is dedicated to the modernization of TCM through scientific innovation and rigorous quality standards. It serves as a vital link in the supply chain for hospitals and pharmacies across China and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Traditional Chinese Medicine.